Logo image of XLO

XILIO THERAPEUTICS INC (XLO) Stock Analyst Ratings

NASDAQ:XLO - Nasdaq - US98422T1007 - Common Stock - Currency: USD

0.7502  0 (-0.64%)

After market: 0.7596 +0.01 (+1.25%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to XLO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.08. This target is 443.85% above the current price.
XLO was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about XLO.
In the previous month the buy percentage consensus was at a similar level.
XLO was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

XLO Historical Analyst RatingsXLO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.754.044.084.084.20 - 438.52% 443.85% 443.85% 459.85%

Related screens

XLO Current Analyst RatingXLO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-11-08 Raymond James Maintains Outperform -> Outperform
2023-05-30 Chardan Capital Reiterate Buy -> Buy
2023-05-11 Chardan Capital Reiterate Buy
2023-01-27 Morgan Stanley Maintains Overweight
2022-12-21 Chardan Capital Initiate Buy
2022-11-10 Raymond James Maintains Outperform
2022-08-10 Morgan Stanley Maintains Overweight
2022-01-10 HC Wainwright & Co. Initiate Buy
2021-11-16 Cowen & Co. Initiate Outperform
2021-11-16 Raymond James Initiate Outperform
2021-11-16 Morgan Stanley Initiate Overweight